Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Danish focus on bio chemicals

The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.

Medtech giant separates

Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.

Control of blood vessels can treat obesity

Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.

Swedish cancer therapy granted

Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

New nano professor in Denmark

The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antibiotic-resistant bacteria. That is stated in a report commissioned by the Swedish government.

Academy for a new turn at work

Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Sales Representative, Applied Biosystems

New head of Vinnova

While waiting for a new gerenal-director, Vinnova has got a substitute general-director.

Fat cells' reaction differs with body weight

The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organization TNO Quality of Life.

Pfizer buys Swiss vaccines

Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.